Old Web
English
Sign In
Acemap
>
authorDetail
>
David Lopez y Niedenhoff
David Lopez y Niedenhoff
Oncology
Internal medicine
Multiple myeloma
Medicine
Immunology
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?
2022
BMC Medical Imaging
Romans Zukovs
Christina Antke
Eduards Mamlins
Lino Morris Sawicki
Annemarie Mohring
David Lopez y Niedenhoff
Amelie Boquoi
Mustafa Kondakci
Gerald Antoch
Hans Wilhelm Müller
Roland Fenk
Rainer Haas
Show All
Source
Cite
Save
Citations (0)
Therapy-Related Myeloid Neoplasms Following Treatment for Multiple Myeloma : A Single-Center Analysis
2019
Blood
Amelie Boquoi
Soraya Magdalena Banahan
Judith Strapatsas
David Lopez y Niedenhoff
Guido Kobbe
Norbert Gattermann
Ulrich Germing
Rainer Haas
Thomas Schroeder
Roland Fenk
Show All
Source
Cite
Save
Citations (1)
Similar Quality of Life with 5mg Versus 25mg Lenalidomide Maintenance after First-Line High-Dose Therapy and Autologous Blood Stem Cell Transplantation for Multiple Myeloma: Results of the Lenamain Trial
2018
Blood
Amelie Boquoi
Aristoteles Giagounidis
Hartmut Goldschmidt
M. Heinsch
Mathias J. Rummel
Nicolaus Kroeger
David Lopez y Niedenhoff
C. Matthias Wilk
Ingrida Savickaite
Elias K. Mai
Carlo Aul
Judith Strapatsas
Ariane Dienst
Mustafa Kondakci
Rainer Haas
Guido Kobbe
Roland Fenk
Show All
Source
Cite
Save
Citations (1)
1